Free Access
Med Sci (Paris)
Volume 18, Number 8-9, Août–Septembre 2002
Page(s) 799 - 801
Section Le Magazine : Nouvelles
Published online 15 August 2002
  1. Cesselin F. Endomorphines, récepteurs des opioïdes et nociception. In : Brasseur L, Chauvin M, Guilbaud G, eds. Douleurs, bases fondamentales, pharmacologie, douleurs aiguës, douleurs chroniques, thérapeutiques. Paris : Maloine, 1997: 65–76. [Google Scholar]
  2. Zadina JE, Hackler L, Ge LJ, Kastin AJ. A potent and selective endogenous agonist for the µ-opiate receptor. Nature 1997; 386 : 499–502. [Google Scholar]
  3. Cesselin F, Benoliel JJ, Bourgoin S, Collin E, Pohl M, Hamon M. Spinal mechanisms of opioid analgesia. In : Stein C, ed. Opioids in pain control : basic and clinical aspects, Cambridge : Cambridge University Press, 1999 : 70–95. [Google Scholar]
  4. Carrion AM, Mellström B, Naranjo JR. Protein kinase A-dependent derepression of the human prodynorphin gene via differential binding to an intragenic silencer element. Mol Cell Biol 1998; 18 : 6921–9. [Google Scholar]
  5. Carrion AM, Link WA, Ledo F, Mellström B, Naranjo JR. DREAM is a Ca2+-regulated transcriptional repressor. Nature 1999; 398 : 80–4. [Google Scholar]
  6. Cheng HYM, Pitcher GM, Laviolette SR, et al. DREAM is a critical transcriptional repressor for pain modulation. Cell 2002; 108 : 31–43. [Google Scholar]
  7. Dhawan BN, Cesselin F, Raghubir R, et al. International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev 1996; 48 : 567–92. [Google Scholar]
  8. Naranjo JR, Mellström B, Acaval M, Sassone-Corsi P. Molecular pathways of pain: Fos/Jun-mediated activation of a noncanonical AP-1 site in the prodynorphin gene. Neuron 1991; 6 : 607–17. [Google Scholar]
  9. Tsou K, Khachaturian H, Akil H, Watson SJ. Immunocytochemical localization of pro-opiomelanocortin-derived peptides in the adult rat spinal cord. Brain Res 1986; 378 : 28–35. [Google Scholar]
  10. Laughlin TM, Vanderah TW, Lashbrook J, et al. Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain 1997; 72 : 253–60. [Google Scholar]
  11. Wang Z, Gardell LR, Ossipov MH, et al. Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J Neurosci 2001; 21 : 1779–86. [Google Scholar]
  12. Gerlai R. Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci 1996; 19 : 177–81. [Google Scholar]
  13. Buxbaum JD, Choi EK, Luo Y, et al. Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presinilin fragment. Nat Med 1998; 10 : 1177–81. [Google Scholar]
  14. An WF, Bowlby MR, Betty M, et al. Modulation of A-type potassium channels by a family of calcium sensors. Nature 2000; 403 : 553–6. [Google Scholar]
  15. Fedula SA, Vasiliyev DV, Veselovsky NS. Voltage-operated potassium currents in the somatic membrane of rat dorsal root ganglion neurons: ontogenic aspects. Neuroscience 1998; 85 : 497–508. [Google Scholar]
  16. Spreafico F, Barski JJ, Farina C, Meyer M. Mouse DREAM/calselinin/KChIP3: gene structure, coding potential, and expression. Mol Cell Neurosci 2001; 17 : 1–16. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.